His main research concerns Prostate cancer, Prostate, Pathology, Cancer and Internal medicine. He does research in Prostate cancer, focusing on Prostate-specific antigen specifically. His work carried out in the field of Prostate brings together such families of science as Surgery, Biopsy, Radiology and Contrast.
His Pathology research incorporates elements of Bladder cancer, Epithelial cell adhesion molecule, Tumor marker and Circulating tumor cell. He has researched Cancer in several fields, including Progressive disease, Cancer research, Logistic regression and Paxillin. His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and Oncology.
His primary areas of investigation include Prostate cancer, Internal medicine, Oncology, Surgery and Prostate. His biological study spans a wide range of topics, including Radiation therapy and Urology. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Gynecology.
The various areas that Leonard G. Gomella examines in his Surgery study include Nephrectomy and Radical retropubic prostatectomy. His work in Prostate covers topics such as Biopsy which are related to areas like Prostate biopsy. The study incorporates disciplines such as Cancer research and Pathology in addition to Cancer.
His primary scientific interests are in Prostate cancer, Internal medicine, Oncology, Prostate and Prostatectomy. The subject of his Prostate cancer research is within the realm of Cancer. Leonard G. Gomella interconnects Germline mutation and Antibiotic prophylaxis in the investigation of issues within Internal medicine.
The study incorporates disciplines such as Genetic testing, Androgen deprivation therapy, Radiation therapy and Germline in addition to Oncology. His Prostatectomy study also includes
Prostate cancer, Internal medicine, Oncology, Cancer research and Prostate are his primary areas of study. Prostate cancer is a subfield of Cancer that Leonard G. Gomella explores. His Cohort and Male patient study in the realm of Internal medicine interacts with subjects such as Rucaparib, Olaparib and Periprosthetic.
His Oncology study integrates concerns from other disciplines, such as Precision medicine, Germline mutation, Germline, Androgen deprivation therapy and Genetic testing. While the research belongs to areas of Cancer research, Leonard G. Gomella spends his time largely on the problem of Transcription factor, intersecting his research to questions surrounding Genetic screen, Prostate-specific antigen and Messenger RNA. His Prostate research integrates issues from Urinary system, Median follow-up, Brachytherapy and Toxicity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of dutasteride on the risk of prostate cancer.
Gerald L. Andriole;David G. Bostwick;Otis W. Brawley;Leonard G. Gomella.
The New England Journal of Medicine (2010)
Micro-RNA profiling in kidney and bladder cancers
Fedra Gottardo;Fedra Gottardo;Chang Gong Liu;Manuela Ferracin;George A. Calin.
Urologic Oncology-seminars and Original Investigations (2007)
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.
Raffaele Baffa;Matteo Fassan;Matteo Fassan;Stefano Volinia;Brian O'Hara.
The Journal of Pathology (2009)
Detection of hematogenous micrometastasis in patients with prostate cancer
J G Moreno;C M Croce;R Fischer;M Monne.
Cancer Research (1992)
Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs
Eric Londina;Phillipe Lohera;Aristeidis G. Telonis;Kevin Quann.
Proceedings of the National Academy of Sciences of the United States of America (2015)
A Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Carcinoma In Situ in Patients With Bladder Cancer: A Phase III, Multicenter Study
Yves Fradet;H. Barton Grossman;Leonard Gomella;Seth Lerner.
The Journal of Urology (2007)
Utilization of polymerase chain reaction technology in the detection of solid tumors
Ganesh V. Raj M.D.;Jose G. Moreno;Leonard G. Gomella.
A Phase III, Multicenter Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Superficial Papillary Lesions in Patients With Bladder Cancer
H. Barton Grossman;Leonard Gomella;Yves Fradet;Alvaro Morales.
The Journal of Urology (2007)
CHEMOPREVENTION OF PROSTATE CANCER IN MEN AT HIGH RISK: RATIONALE AND DESIGN OF THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL
Gerald Andriole;David Bostwick;Otis Brawley;Leonard Gomella.
The Journal of Urology (2004)
Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer.
Gary R. Hudes;Faith Nathan;Christina Khater;Naomi Haas.
Journal of Clinical Oncology (1997)
Canadian Journal of Urology
(Impact Factor: 1.683)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: